Mirae Asset Global ETFs Holdings
REGN icon

Mirae Asset Global ETFs Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.2M Sell
59,595
-10,259
-15% -$6.98M 0.04% 363
2026
Q1 		$54M Buy
69,854
+702
+1% +$537K 0.07% 236
2025
Q4 		$53.4M Sell
69,152
-22,231
-24% -$15.1M 0.08% 242
2025
Q3 		$51.3M Buy
91,383
+11,001
+14% +$6.22M 0.08% 242
2025
Q2 		$42.2M Sell
80,382
-7,255
-8% -$4.05M 0.08% 241
2025
Q1 		$55.6M Buy
87,637
+5,118
+6% +$3.52M 0.12% 186
2024
Q4 		$58.8M Buy
82,519
+1,712
+2% +$1.44M 0.12% 175
2024
Q3 		$84.9M Sell
80,807
-3,569
-4% -$3.97M 0.19% 115
2024
Q2 		$88.7M Buy
+84,376
New +$81.8M 0.21% 105

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's REGN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2026, selling an estimated $6.98M and leaving 59,595 shares worth $37.2M. The position accounts for 0.04% of the portfolio, ranked #363.

Mirae Asset Global ETFs Holdings first reported a position in REGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $88.7M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 59,595 shares of Regeneron Pharmaceuticals worth $37.2M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 10,259 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.98M.
  • Regeneron Pharmaceuticals made up 0.04% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #363 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Regeneron Pharmaceuticals position peaked at $88.7M in Q2 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.